World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
48887
World Ranking
6441
National Ranking
3425

Overview

Marwan N. Sabbagh is affiliated with the Lou Ruvo Brain Institute in the United States. Their research primarily focuses on medicine, with specific contributions in psychiatry and mental health, physiology, neurology, radiology, nuclear medicine and imaging, as well as public health, environmental and occupational health.

The scientist's main fields of study encompass various aspects of neurodegenerative diseases and cognitive disorders. Key topics in their work include:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Cholinesterase and Neurodegenerative Diseases
  • Health, Environment, Cognitive Aging
  • Frailty in Older Adults
  • Down syndrome and intellectual disability research
  • Health Systems, Economic Evaluations, Quality of Life

Marwan N. Sabbagh has contributed to multiple peer-reviewed publications. Recent selected papers include:

  • "Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021" (2021), The Journal of Prevention of Alzheimer s Disease
  • "Alzheimer's disease drug development pipeline: 2020" (2020), Alzheimer s & Dementia Translational Research & Clinical Interventions
  • "Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval" (2020), Alzheimer s Research & Therapy
  • "Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis" (2021), Journal of Internal Medicine
  • "Aducanumab produced a clinically meaningful benefit in association with amyloid lowering" (2021), Alzheimer s Research & Therapy

Their frequent co-authors reflect collaborative research efforts in related fields and include:

  • Jeffrey L. Cummings
  • Boris Decourt
  • Aaron Ritter
  • Eric M. Reiman
  • Anna Burke

Marwan N. Sabbagh's publications appear regularly in established venues focused on dementia and Alzheimer's disease research, such as:

  • Alzheimer s & Dementia
  • The Journal of Prevention of Alzheimer s Disease
  • Alzheimer s Research & Therapy
  • Alzheimer s & Dementia Translational Research & Clinical Interventions
  • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring

Best Publications

  • Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

    Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow

  • Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

    Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura

  • Use of Florbetapir-PET for Imaging β-Amyloid Pathology

    Christopher M. Clark;Julie A. Schneider;Barry J. Bedell;Thomas G. Beach

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

    Thomas G. Beach;Charles H. Adler;Lucia I. Sue;Linda Vedders

  • Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.

    Bruno Dubois;Nicolas Villain;Giovanni B. Frisoni;Gil D. Rabinovici

  • Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

    Christopher M Clark;Michael J Pontecorvo;Thomas G Beach;Barry J Bedell

  • A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

    S. Salloway;R. Sperling;S. Gilman;N.C.I. Fox

  • Unified Staging System for Lewy Body Disorders: Correlation with Nigrostriatal Degeneration, Cognitive Impairment and Motor Dysfunction

    Thomas G. Beach;Charles H. Adler;LihFen F. Lue;Lucia I. Sue

  • Four distinct trajectories of tau deposition identified in Alzheimer’s disease

    Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  • Alzheimer's disease drug development pipeline: 2019.

    Jeffrey Cummings;Jeffrey Cummings;Garam Lee;Aaron Ritter;Marwan Sabbagh

  • Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients

    Rena Li;Kristina Lindholm;Li-Bang Yang;Xu Yue

  • Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect

    Richard J. Caselli;Amylou C. Dueck;David Osborne;Marwan N. Sabbagh

  • Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

    Osama Sabri;Marwan N. Sabbagh;John Seibyl;Henryk Barthel

  • Defining mild cognitive impairment in Parkinson's disease.

    John Nathaniel Caviness;Erika M Driver-Dunckley;Donald J. Connor;Marwan N. Sabbagh

  • Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

    D. Larry Sparks;Marwan N. Sabbagh;Donald J. Connor;Jean Lopez

  • Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015.

    Dev Mehta;Robert Jackson;Gaurav Paul;Jiong Shi

  • New acetylcholinesterase inhibitors for Alzheimer's disease.

    Mona Mehta;Abdu Adem;Marwan Sabbagh

  • Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study

    Charles H. Adler;Thomas G. Beach;Joseph G. Hentz;Holly A. Shill

  • Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

    Reisa Sperling;Stephen Salloway;David J Brooks;Donatella Tampieri

Frequent Co-Authors

Charles H. Adler
Charles H. Adler Mayo Clinic
Thomas G. Beach
Thomas G. Beach Banner Health
Holly A. Shill
Holly A. Shill Barrow Neurological Institute
John N. Caviness
John N. Caviness Mayo Clinic
Douglas G. Walker
Douglas G. Walker Arizona State University
Eric M. Reiman
Eric M. Reiman Arizona State University
Mark A. Mintun
Mark A. Mintun University of Pennsylvania
Alex E. Roher
Alex E. Roher Banner Health
Stephen Salloway
Stephen Salloway Brown University
Reisa A. Sperling
Reisa A. Sperling Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those pursuing a medical career in the USA, a range of related online degree programs and alternative pathways can help accelerate your goals or expand your expertise. Many students and professionals now consider programs that offer flexibility, affordability, and quicker routes to professional roles in healthcare.

If you are looking to become a registered nurse or advance your career, exploring an lpn fast track program is an excellent way to enter nursing quickly and efficiently. For those aiming for leadership roles in advanced practice nursing, several affordable dnp programs are available online, making it possible to earn a doctoral degree without high financial barriers.

Mental health is a fast-growing field; if you’re interested in this area, an msn to pmhnp online program can prepare you for specialized practice as a psychiatric mental health nurse practitioner. Alternatively, those desiring a broader administrative or managerial role in healthcare may benefit from pursuing an online health management degree for career advancement.

Best Scientists Citing Marwan N. Sabbagh

Trending Scientists

Recently Published Articles